Document Detail

Medical device reporting: manufacturer reporting, importer reporting, user facility reporting, distributor reporting--FDA. Direct final rule; withdrawal.
MedLine Citation:
PMID:  10182694     Owner:  NLM     Status:  MEDLINE    
The Food and Drug Administration (FDA) published in the Federal Register of May 12, 1998, a proposed rule (63 FR 26129) and a direct final rule (63 FR 26069) to implement amendments to the medical device reporting provisions of the Federal Food, Drug, and Cosmetic Act, as amended by the FDA Modernization Act of 1997 (FDAMA). The comment period closed July 27, 1998. FDA is withdrawing the direct final rule because the agency received significant adverse comment.
Related Documents :
17095824 - A standard ontology for the semantic integration of components in healthcare organizati...
18244064 - Development of pma guidance for ventricular assist devices and total artificial heart.
15624254 - Cardiovascular and neurological devices; reclassification of two embolization devices. ...
24096904 - The use of feathers of birds of prey as indicators of metal pollution.
20530894 - Effects of a chicken extract on food-deprived activity stress in rats.
9401164 - Nutrient intakes of senior women: balancing the low-fat message.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Federal register     Volume:  63     ISSN:  0097-6326     ISO Abbreviation:  Fed Regist     Publication Date:  1998 Aug 
Date Detail:
Created Date:  1998-10-13     Completed Date:  1998-10-13     Revised Date:  2000-12-18    
Medline Journal Info:
Nlm Unique ID:  7808722     Medline TA:  Fed Regist     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  45716-7     Citation Subset:  H    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Device Approval / legislation & jurisprudence*
United States
United States Food and Drug Administration

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Publication of OIG compliance program guidance for clinical laboratories--HHS. Notice.
Next Document:  Medical device warning letter draft pilot; availability--FDA. Notice.